MedTrace Logo

Efficacy and Safety of Intravitreal Triamcinolone Acetonide in Eyes With Post Vitrectomy Diabetic Vitreous Hemorrhage

NCT00300014 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2007-06-13

No results posted yet for this study

Summary

The Purpose of this study is compare the efficacy of intravitreal triamcinolone in clearing recurrent post-vitrectomy diabetic hemorrhage with conventional treatment, air-fluid exchange.

Conditions

  • Post Vitrectomy State
  • Recurrent Diabetic Vitreous Hemorrhage

Interventions

PROCEDURE

Intravitreal triamcinolone injection

PROCEDURE

Air-fluid exchange

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Sun Young Lee, MD · Asan Medical Center

  • He Won Chung, MD · Asan Medical Center

  • Young Hee Yoon, MD · Asan Medical Center

  • June-Gone Kim, MD · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Completion
2007-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00300014 on ClinicalTrials.gov